Tag: Angiogenesis inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Angiogenesis inhibitors

Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on ... - Nature

Added to Collection on: 2022-10-25 19:50:09

Tags for this article:

Clinical medicine
Medicine
Drugs
Angiogenesis inhibitors
Cancer treatments
Orphan drugs
Immunology
Monoclonal antibodies
Ramucirumab
Panitumumab
Bevacizumab
Sorafenib
United States
Amgen

Click the tags to see associated articles and topics

View Article Details
Replimune, Roche to Develop RP3 in Colorectal Cancer, Hepatocellular Carcinoma >REPL

Added to Collection on: 2022-12-07 12:14:46

Tags for this article:

Drugs
Genentech
Life Sciences
Clinical medicine
Cancer treatments
Angiogenesis inhibitors
Atezolizumab
Bevacizumab
Bristol-Myers Squibb
RP2
Regeneron Pharmaceuticals
REPLIMUNE

Click the tags to see associated articles and topics

View Article Details
Anti-Vascular Endothelial Growth Factor Therapeutics market is expected to reach a US ... - Benzinga

Added to Collection on: 2022-12-20 14:28:57

Tags for this article:

Medicine
Clinical medicine
Health
Breakthrough therapy
Angiogenesis inhibitors
Genentech
Angiology
Cancer treatments
Aflibercept
Macular edema
Ranibizumab
Bevacizumab

Click the tags to see associated articles and topics

View Article Details
Outlook Therapeutics® Announces Validation of Marketing Authorization Application by the ...

Added to Collection on: 2022-12-23 10:58:16

Tags for this article:

Drugs
Branches of biology
Medicine
RTT
Cancer treatments
Genentech
Angiogenesis inhibitors
Bevacizumab
Macular degeneration
Vascular endothelial growth factor
VEGF receptor
Anti–vascular endothelial growth factor therapy
Outlook Therapeutics Inc.
United States

Click the tags to see associated articles and topics

View Article Details
European regulator endorses high-dose version of Bayer eye drug Eylea | Reuters

Added to Collection on: 2023-11-10 19:38:59

Tags for this article:

Angiogenesis inhibitors
Breakthrough therapy
Monoclonal antibodies
Aflibercept
Sanofi
Macular edema
Regeneron Pharmaceuticals
Macular degeneration
Faricimab
Pharmaceutical industry
Bayer
Rinucumab
Eylea

Click the tags to see associated articles and topics

View Article Details
EyePoint sees stock surge on AMD drug trial data | BioPharma Dive

Added to Collection on: 2023-12-04 16:48:07

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Breakthrough therapy
Sanofi
Regeneron Pharmaceuticals
Macular degeneration
Macula
EyePoint Pharmaceuticals
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
Ranibizumab (Lucentis) Biosimilars Pipeline Review 2023: Information on Approved Drugs ...

Added to Collection on: 2023-12-15 11:15:13

Tags for this article:

Angiogenesis inhibitors
Orphan drugs
Monoclonal antibodies
Breakthrough therapy
Ranibizumab
Macular edema
Central retinal vein occlusion
Biosimilar
Choroidal neovascularization
Genentech
Diabetic retinopathy
Macular degeneration

Click the tags to see associated articles and topics

View Article Details
Innovent Announces Retirement of CFO and Appointment of New CFO - Yahoo Finance

Added to Collection on: 2024-02-05 18:34:47

Tags for this article:

Specialty drugs
Orphan drugs
Monoclonal antibodies
Angiogenesis inhibitors
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
Incyte
Adalimumab
Bevacizumab
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Choroidal Neovascularization Market to Exhibit Rapid Growth Rate During the Forecast ...

Added to Collection on: 2024-03-02 20:05:46

Tags for this article:

Angiogenesis inhibitors
Choroidal neovascularization
Ophthalmology
Ranibizumab
Neovascularization
Macular degeneration

Click the tags to see associated articles and topics

View Article Details
Regeneron v Novartis and Vetter: Walker Process Client Update | Polsinelli - JDSupra

Added to Collection on: 2024-03-26 20:46:42

Tags for this article:

Angiogenesis inhibitors
Sanofi
Monoclonal antibodies
Orphan drugs
Aflibercept
Novartis
Anti-VEGF
Ranibizumab
Vascular endothelial growth factor
Regeneron Pharmaceuticals
Genentech
AMD
United States

Click the tags to see associated articles and topics

View Article Details